A mouse model was established using the HNSCC line, SCC7, and was used to evaluate therapeutic effects of PDT-DC vaccine in facilitating anti-tumor immunity of PD-L1 antibody. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.